Published in
Springer, Cancer Immunology, Immunotherapy, 11(51), p. 630-636, 2002
DOI: 10.1007/s00262-002-0323-1
Links
Tools
Phase I/II study of sequential chemoimmunotherapy (SCIT) for metastatic melanoma: outpatient treatment with dacarbazine, granulocyte-macrophage colony-stimulating factor, low-dose interleukin-2, and interferon-alpha
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 